PCS-话题@MedSci

#PCS#

107篇内容 | 2990人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1685605, encodeId=83ca1685605ca, content=<a href='/topic/show?id=a340138e48a' target=_blank style='color:#2F92EE;'>#PCS#</a>, objectTitle=阜外医院李建军等研究：血PCSK9水平能预测冠状动脉钙化程度, objectType=article, longId=131660, objectId=36b51316600f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=36b51316600f, replyNumber=0, likeNumber=77, createdTime=2018-11-13, rootId=0, userName=Tamikia, userId=173d28230918, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=36b51316600f, moduleTitle=阜外医院李建军等研究：血PCSK9水平能预测冠状动脉钙化程度, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=36b51316600f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1685600, encodeId=47e816856002a, content=<a href='/topic/show?id=a340138e48a' target=_blank style='color:#2F92EE;'>#PCS#</a>, objectTitle=Cleveland Clinic：把脉2018十大医疗科技创新，PCSK9抑制剂入选, objectType=article, longId=122312, objectId=0eb0122312c0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0eb0122312c0, replyNumber=0, likeNumber=75, createdTime=2017-12-29, rootId=0, userName=Tamikia, userId=173d28230918, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0eb0122312c0, moduleTitle=Cleveland Clinic：把脉2018十大医疗科技创新，PCSK9抑制剂入选, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0eb0122312c0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1685590, encodeId=19271685590e1, content=<a href='/topic/show?id=a340138e48a' target=_blank style='color:#2F92EE;'>#PCS#</a>, objectTitle=NEJM：PCSK9抑制剂Bococizumab由于高血脂治疗, objectType=article, longId=96527, objectId=5abd9652e42, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5abd9652e42, replyNumber=0, likeNumber=67, createdTime=2018-01-22, rootId=0, userName=Tamikia, userId=173d28230918, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5abd9652e42, moduleTitle=NEJM：PCSK9抑制剂Bococizumab由于高血脂治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5abd9652e42)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1685598, encodeId=ea2f1685598bc, content=<a href='/topic/show?id=a340138e48a' target=_blank style='color:#2F92EE;'>#PCS#</a>, objectTitle=Metabolism：杂合子家族性高胆固醇血症Lp（a）与PCSK9之间的相关性分析！, objectType=article, longId=119753, objectId=0906119e53cd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0906119e53cd, replyNumber=0, likeNumber=74, createdTime=2018-10-19, rootId=0, userName=Tamikia, userId=173d28230918, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0906119e53cd, moduleTitle=Metabolism：杂合子家族性高胆固醇血症Lp（a）与PCSK9之间的相关性分析！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0906119e53cd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1685595, encodeId=0cd91685595c9, content=<a href='/topic/show?id=a340138e48a' target=_blank style='color:#2F92EE;'>#PCS#</a>, objectTitle=Blood：TGF-β诱导的内源性PAI-1调控HSPCs停留在骨髓基质。, objectType=article, longId=110300, objectId=ef5411030015, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ef5411030015, replyNumber=0, likeNumber=61, createdTime=2018-01-13, rootId=0, userName=Tamikia, userId=173d28230918, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ef5411030015, moduleTitle=Blood：TGF-β诱导的内源性PAI-1调控HSPCs停留在骨髓基质。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ef5411030015)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1685591, encodeId=1c691685591ee, content=<a href='/topic/show?id=a340138e48a' target=_blank style='color:#2F92EE;'>#PCS#</a>, objectTitle=Diabetes Care：高血清PCSK9与肾移植接受者移植后新发糖尿病的风险增加相关！, objectType=article, longId=97797, objectId=230d9e797f1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=230d9e797f1, replyNumber=0, likeNumber=57, createdTime=2018-02-28, rootId=0, userName=Tamikia, userId=173d28230918, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=230d9e797f1, moduleTitle=Diabetes Care：高血清PCSK9与肾移植接受者移植后新发糖尿病的风险增加相关！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=230d9e797f1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1685592, encodeId=f0051685592bb, content=<a href='/topic/show?id=a340138e48a' target=_blank style='color:#2F92EE;'>#PCS#</a>, objectTitle=JAHA：循环中PCSK9水平与动脉硬化相关吗？, objectType=article, longId=98103, objectId=7d19981037f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7d19981037f, replyNumber=0, likeNumber=59, createdTime=2017-07-16, rootId=0, userName=Tamikia, userId=173d28230918, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7d19981037f, moduleTitle=JAHA：循环中PCSK9水平与动脉硬化相关吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7d19981037f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1685599, encodeId=c4a416855996c, content=<a href='/topic/show?id=a340138e48a' target=_blank style='color:#2F92EE;'>#PCS#</a>, objectTitle=Pak J Pharm Sci：Ad-BMP-2-IRES-HIF-1α转染的EPCs具有较强的血管生成和成骨能力, objectType=article, longId=122112, objectId=cf8e1221125e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cf8e1221125e, replyNumber=0, likeNumber=59, createdTime=2018-04-07, rootId=0, userName=Tamikia, userId=173d28230918, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cf8e1221125e, moduleTitle=Pak J Pharm Sci：Ad-BMP-2-IRES-HIF-1α转染的EPCs具有较强的血管生成和成骨能力, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cf8e1221125e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1685587, encodeId=f69a168558ea9, content=<a href='/topic/show?id=a340138e48a' target=_blank style='color:#2F92EE;'>#PCS#</a>, objectTitle=Nature：PCSK9基因靶向胆固醇药物促进心脏健康, objectType=article, longId=92904, objectId=7fe0929044e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7fe0929044e, replyNumber=0, likeNumber=57, createdTime=2018-01-02, rootId=0, userName=Tamikia, userId=173d28230918, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7fe0929044e, moduleTitle=Nature：PCSK9基因靶向胆固醇药物促进心脏健康, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7fe0929044e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1685586, encodeId=053316855864f, content=<a href='/topic/show?id=a340138e48a' target=_blank style='color:#2F92EE;'>#PCS#</a>, objectTitle=Eur Heart J：PCSK9单克隆抗体可以逆转家族性高胆固醇血症患者单核细胞促炎效应, objectType=article, longId=89406, objectId=aea88940615, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aea88940615, replyNumber=0, likeNumber=102, createdTime=2017-06-25, rootId=0, userName=Tamikia, userId=173d28230918, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aea88940615, moduleTitle=Eur Heart J：PCSK9单克隆抗体可以逆转家族性高胆固醇血症患者单核细胞促炎效应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aea88940615)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1685593, encodeId=2566168559356, content=<a href='/topic/show?id=a340138e48a' target=_blank style='color:#2F92EE;'>#PCS#</a>, objectTitle=JCEM：PCSK9的功能丧失变异能降低空腹和餐后脂肪及脂蛋白, objectType=article, longId=105948, objectId=b2c01059482b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b2c01059482b, replyNumber=0, likeNumber=0, createdTime=2017-08-02, rootId=0, userName=Tamikia, userId=173d28230918, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b2c01059482b, moduleTitle=JCEM：PCSK9的功能丧失变异能降低空腹和餐后脂肪及脂蛋白, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b2c01059482b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1685584, encodeId=7c08168558448, content=<a href='/topic/show?id=a340138e48a' target=_blank style='color:#2F92EE;'>#PCS#</a>, objectTitle=JAMA：脑震荡后要休息？NO！早期运动才可降低PPCS的发生风险！, objectType=article, longId=85014, objectId=7386850145f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7386850145f, replyNumber=0, likeNumber=83, createdTime=2017-02-04, rootId=0, userName=Tamikia, userId=173d28230918, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7386850145f, moduleTitle=JAMA：脑震荡后要休息？NO！早期运动才可降低PPCS的发生风险！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7386850145f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1685583, encodeId=645e1685583fa, content=<a href='/topic/show?id=a340138e48a' target=_blank style='color:#2F92EE;'>#PCS#</a>, objectTitle=NEJM：一个持久的PCSK9干扰RNAi治疗抑制剂-Inclisiran, objectType=article, longId=82353, objectId=14948235311, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=14948235311, replyNumber=0, likeNumber=52, createdTime=2016-12-17, rootId=0, userName=Tamikia, userId=173d28230918, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=14948235311, moduleTitle=NEJM：一个持久的PCSK9干扰RNAi治疗抑制剂-Inclisiran, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=14948235311)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1685588, encodeId=820d16855881c, content=<a href='/topic/show?id=a340138e48a' target=_blank style='color:#2F92EE;'>#PCS#</a>, objectTitle=Eur Heart J.：PCSK9单克隆抗体逆转家族性高胆固醇血症中单核细胞的促炎特征, objectType=article, longId=94682, objectId=267794682ec, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=267794682ec, replyNumber=0, likeNumber=63, createdTime=2017-07-15, rootId=0, userName=Tamikia, userId=173d28230918, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=267794682ec, moduleTitle=Eur Heart J.：PCSK9单克隆抗体逆转家族性高胆固醇血症中单核细胞的促炎特征, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=267794682ec)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1685589, encodeId=361616855898c, content=<a href='/topic/show?id=a340138e48a' target=_blank style='color:#2F92EE;'>#PCS#</a>, objectTitle=NEJM：inclisiran可显著降低患者LDL胆固醇和PCSK9水平, objectType=article, longId=95701, objectId=97af95e0133, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=97af95e0133, replyNumber=0, likeNumber=120, createdTime=2017-05-27, rootId=0, userName=Tamikia, userId=173d28230918, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=97af95e0133, moduleTitle=NEJM：inclisiran可显著降低患者LDL胆固醇和PCSK9水平, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=97af95e0133)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1685579, encodeId=2db816855e9a2, content=<a href='/topic/show?id=a340138e48a' target=_blank style='color:#2F92EE;'>#PCS#</a>, objectTitle=PCSK9抑制剂终于挺进英国！赛诺菲/安进降胆固醇药物 Praluent/Repatha同获NICE支持, objectType=article, longId=68075, objectId=8d55680e57d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8d55680e57d, replyNumber=0, likeNumber=69, createdTime=2017-02-17, rootId=0, userName=Tamikia, userId=173d28230918, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8d55680e57d, moduleTitle=PCSK9抑制剂终于挺进英国！赛诺菲/安进降胆固醇药物 Praluent/Repatha同获NICE支持, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8d55680e57d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1685585, encodeId=ee7f168558576, content=<a href='/topic/show?id=a340138e48a' target=_blank style='color:#2F92EE;'>#PCS#</a>, objectTitle=《柳叶刀》子刊：新型降脂药PCSK9抑制剂可能也轻度升高血糖, objectType=article, longId=85990, objectId=77eb85990a9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=77eb85990a9, replyNumber=0, likeNumber=61, createdTime=2017-07-11, rootId=0, userName=Tamikia, userId=173d28230918, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=77eb85990a9, moduleTitle=《柳叶刀》子刊：新型降脂药PCSK9抑制剂可能也轻度升高血糖, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=77eb85990a9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1685582, encodeId=5a4c16855827c, content=<a href='/topic/show?id=a340138e48a' target=_blank style='color:#2F92EE;'>#PCS#</a>, objectTitle=Lancet Oncol：光敏剂TPCS2a安全性和耐受性研究, objectType=article, longId=77079, objectId=c214e70796a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c214e70796a, replyNumber=0, likeNumber=56, createdTime=2017-01-30, rootId=0, userName=Tamikia, userId=173d28230918, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c214e70796a, moduleTitle=Lancet Oncol：光敏剂TPCS2a安全性和耐受性研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c214e70796a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1685581, encodeId=a38c168558112, content=<a href='/topic/show?id=a340138e48a' target=_blank style='color:#2F92EE;'>#PCS#</a>, objectTitle=JAMA：治疗杂合子FH或ASCVD，PCSK9抑制剂的使用并未达到其成本效益, objectType=article, longId=75393, objectId=b83fe5393ff, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b83fe5393ff, replyNumber=0, likeNumber=66, createdTime=2016-11-30, rootId=0, userName=Tamikia, userId=173d28230918, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b83fe5393ff, moduleTitle=JAMA：治疗杂合子FH或ASCVD，PCSK9抑制剂的使用并未达到其成本效益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b83fe5393ff)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1685577, encodeId=1d6b16855e76f, content=<a href='/topic/show?id=a340138e48a' target=_blank style='color:#2F92EE;'>#PCS#</a>, objectTitle=进新一代降脂药PCSK9抑制剂Repatha治疗他汀不耐受高胆固醇血症III期研究获得成功, objectType=article, longId=63537, objectId=661e6353e48, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=661e6353e48, replyNumber=0, likeNumber=81, createdTime=2016-09-05, rootId=0, userName=Tamikia, userId=173d28230918, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=661e6353e48, moduleTitle=进新一代降脂药PCSK9抑制剂Repatha治疗他汀不耐受高胆固醇血症III期研究获得成功, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=661e6353e48)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

PCS

2020-05-29

Tamikia (审核中...)

前往app查看评论内容

#PCS#

阜外医院李建军等研究：血PCSK9水平能预测冠状动脉钙化程度

2018-11-13

Tamikia (审核中...)

前往app查看评论内容

#PCS#

Cleveland Clinic：把脉2018十大医疗科技创新，PCSK9抑制剂入选

2017-12-29

Tamikia (审核中...)

前往app查看评论内容

#PCS#

NEJM：PCSK9抑制剂Bococizumab由于高血脂治疗

2018-01-22

Tamikia (审核中...)

前往app查看评论内容

#PCS#

Metabolism：杂合子家族性高胆固醇血症Lp（a）与PCSK9之间的相关性分析！

2018-10-19

Tamikia (审核中...)

前往app查看评论内容

#PCS#

Blood：TGF-β诱导的内源性PAI-1调控HSPCs停留在骨髓基质。

2018-01-13

Tamikia (审核中...)

前往app查看评论内容

#PCS#

Diabetes Care：高血清PCSK9与肾移植接受者移植后新发糖尿病的风险增加相关！

2018-02-28

Tamikia (审核中...)

前往app查看评论内容

#PCS#

JAHA：循环中PCSK9水平与动脉硬化相关吗？

2017-07-16

Tamikia (审核中...)

前往app查看评论内容

#PCS#

Pak J Pharm Sci：Ad-BMP-2-IRES-HIF-1α转染的EPCs具有较强的血管生成和成骨能力

2018-04-07

Tamikia (审核中...)

前往app查看评论内容

#PCS#

Nature：PCSK9基因靶向胆固醇药物促进心脏健康

2018-01-02

Tamikia (审核中...)

前往app查看评论内容

#PCS#

Eur Heart J：PCSK9单克隆抗体可以逆转家族性高胆固醇血症患者单核细胞促炎效应

2017-06-25

Tamikia (审核中...)

前往app查看评论内容

#PCS#

JCEM：PCSK9的功能丧失变异能降低空腹和餐后脂肪及脂蛋白

2017-08-02

Tamikia (审核中...)

前往app查看评论内容

#PCS#

JAMA：脑震荡后要休息？NO！早期运动才可降低PPCS的发生风险！

2017-02-04

Tamikia (审核中...)

前往app查看评论内容

#PCS#

NEJM：一个持久的PCSK9干扰RNAi治疗抑制剂-Inclisiran

2016-12-17

Tamikia (审核中...)

前往app查看评论内容

#PCS#

Eur Heart J.：PCSK9单克隆抗体逆转家族性高胆固醇血症中单核细胞的促炎特征

2017-07-15

Tamikia (审核中...)

前往app查看评论内容

#PCS#

NEJM：inclisiran可显著降低患者LDL胆固醇和PCSK9水平

2017-05-27

Tamikia (审核中...)

前往app查看评论内容

#PCS#

PCSK9抑制剂终于挺进英国！赛诺菲/安进降胆固醇药物 Praluent/Repatha同获NICE支持

2017-02-17

Tamikia (审核中...)

前往app查看评论内容

#PCS#

《柳叶刀》子刊：新型降脂药PCSK9抑制剂可能也轻度升高血糖

2017-07-11

Tamikia (审核中...)

前往app查看评论内容

#PCS#

Lancet Oncol：光敏剂TPCS2a安全性和耐受性研究

2017-01-30

Tamikia (审核中...)

前往app查看评论内容

#PCS#

JAMA：治疗杂合子FH或ASCVD，PCSK9抑制剂的使用并未达到其成本效益

2016-11-30

Tamikia (审核中...)

前往app查看评论内容

#PCS#

进新一代降脂药PCSK9抑制剂Repatha治疗他汀不耐受高胆固醇血症III期研究获得成功

2016-09-05

科室
- - 订阅+
  - 更多科室
工具
服务